HomeInsightsStock Comparison

Chemo Pharma Laboratories Ltd vs Marksans Pharma Ltd Stock Comparison

Chemo Pharma Laboratories Ltd vs Marksans Pharma Ltd Stock Comparison

Last Updated on: Jun 26, 2025

Key Highlights

  • The Latest Trading Price of Chemo Pharma Laboratories Ltd is ₹ 117.55 as of 25 Jun 15:30.
  • The P/E Ratio of Chemo Pharma Laboratories Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Marksans Pharma Ltd changed from 4.7 on March 2020 to 21.9 on March 2024 . This represents a CAGR of 36.04% over 5 years.
  • The Market Cap of Chemo Pharma Laboratories Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Marksans Pharma Ltd changed from ₹ 568.95 crore on March 2020 to ₹ 6867 crore on March 2024 . This represents a CAGR of 64.57% over 5 years.
  • The revenue of Chemo Pharma Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Marksans Pharma Ltd for the Mar '25 is ₹ 724.98 crore as compare to the Dec '24 revenue of ₹ 709.7 crore. This represent the growth of 2.15%.
  • The ebitda of Chemo Pharma Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Marksans Pharma Ltd for the Mar '25 is ₹ 142.27 crore as compare to the Dec '24 ebitda of ₹ 166.61 crore. This represent the decline of -14.61%.
  • The net profit of Chemo Pharma Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Marksans Pharma Ltd changed from ₹ 70.44 crore to ₹ 90.73 crore over 8 quarters. This represents a CAGR of 13.49% .
  • The Dividend Payout of Chemo Pharma Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Marksans Pharma Ltd changed from 10.8 % on March 2020 to 20.33 % on March 2024 . This represents a CAGR of 13.49% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Chemo Pharma Laboratories Ltd

  • Chemo Pharma Laboratories Limited was established in August, 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs.
  • However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues.
  • Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential.
  • The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals.

About Marksans Pharma Ltd

  • Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982.
  • Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited with effect from 10th October, 2005.
  • The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
  • The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s.
  • Marksans Pharma Limited (formerly M/s.

Chemo Pharma Laboratories Ltd News Hub

News

Chemo Pharma Laboratories to convene board meeting

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

15 May 2025 14:48

News

Chemo Pharma Laboratories to conduct board meeting

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

09 Apr 2025 09:16

News

Chemo Pharma Laboratories to table results

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

15 Jan 2025 10:12

News

Chemo Pharma Laboratories to announce Quarterly Result

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

17 Oct 2024 10:35

News

Chemo Pharma Laboratories AGM scheduled

Chemo Pharma Laboratories announced that the 82th Annual General Meeting (AGM) of the comp...

Read more

30 Jul 2024 17:11

News

Chemo Pharma Laboratories to convene board meeting

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

10 Jul 2024 09:29

Marksans Pharma Ltd News Hub

News

Marksans Pharma's UK arm gets marketing nod for Oxybutynin Oral solution from UKMHRA

Oxybutynin is used in the treatment of overactive bladder (OAB) symptoms. OAB is a collect...

Read more

19 Jun 2025 10:04

News

Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

30 May 2025 09:13

News

Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK

Metformin Hydrochloride is a widely prescribed medication used for the management of type-...

Read more

30 May 2025 09:33

News

Board of Marksans Pharma recommends final dividend

Marksans Pharma announced that the Board of Directors of the Company at its meeting held o...

Read more

20 May 2025 12:49

News

Relonchem receives marketing authorization for Sennosides 7.5 mg tablets

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

19 May 2025 13:29

News

Relonchem receives marketing authorization for Gabapentin 50 mg/ml oral solution

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

15 May 2025 09:45

SWOT Analysis Of Chemo Pharma Laboratories Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Marksans Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Chemo Pharma Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Marksans Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Chemo Pharma Laboratories Ltd and Marksans Pharma Ltd

Which company has a larger market capitalization, Chemo Pharma Laboratories Ltd or Marksans Pharma Ltd?

Market cap of Chemo Pharma Laboratories Ltd is 17 Cr while Market cap of Marksans Pharma Ltd is 11,193 Cr

What are the key factors driving the stock performance of Chemo Pharma Laboratories Ltd and Marksans Pharma Ltd?

The stock performance of Chemo Pharma Laboratories Ltd and Marksans Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chemo Pharma Laboratories Ltd and Marksans Pharma Ltd?

As of June 26, 2025, the Chemo Pharma Laboratories Ltd stock price is INR ₹117.55. On the other hand, Marksans Pharma Ltd stock price is INR ₹247.0.

How do dividend payouts of Chemo Pharma Laboratories Ltd and Marksans Pharma Ltd compare?

To compare the dividend payouts of Chemo Pharma Laboratories Ltd and Marksans Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions